News Releases

Cannabix Technologies makes “50 B.C. Innovations to Watch List” with Marijuana Breathalyzer, Added to CSE25 Index

November 14, 2017

Vancouver, British Columbia, November 14, 2017 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that the Company has been listed as one of the “50 Innovations to Watch” in British Columbia by Business in Vancouver (“BIV”) magazine. According to BIV, the special edition magazine, “lists 50 made in B.C. innovations that are making waves across the province, the country and the world.”  The list includes companies from a wide range of industries such as technology, financial services, clean tech and consumer products, and includes prominent B.C. companies like Lululemon Athletica, Ballard Power Systems, and Mogo Finance. BIV is a leading B.C. business magazine, the link to the special edition magazine is:
The Company also reports that Cannabix Technologies (CSE: BLO) has qualified for the Canadian Securities Exchange 25 Index (known as the CSE25 Index) as one of the twenty-five largest companies in the CSE Composite Index.
The CSE25 Index is a subgroup of the CSE Composite Index.  The composite index launched in 2015 and includes almost half of the exchange’s listed companies and covers over 75% of the trading activity on the exchange. The new index includes the top twenty-five securities by market capitalization contained in the composite index. These companies account for over 50% of the weighting in the larger index and are typically stocks that attract considerable trading volume.

About Cannabix Technologies Inc

Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many global jurisdictions. Cannabix is working to develop drug-testing devices that will detect THC- the psychoactive component of marijuana that causes intoxication- using breath samples. In particular, Cannabix is focused on developing breath testing devices for detection of recent use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects use days or even weeks earlier. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.